| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2409747
Max Phase: Preclinical
Molecular Formula: C17H30N2O3S
Molecular Weight: 342.51
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC1(C)CC(NC2=NS(=O)(=O)[C@@H]3CCCC[C@@H]3O2)CC(C)(C)C1
Standard InChI: InChI=1S/C17H30N2O3S/c1-16(2)9-12(10-17(3,4)11-16)18-15-19-23(20,21)14-8-6-5-7-13(14)22-15/h12-14H,5-11H2,1-4H3,(H,18,19)/t13-,14+/m0/s1
Standard InChI Key: JRCPLDOXUGPKJL-UONOGXRCSA-N
Associated Targets(Human)
Liver microsomes 16955 Activities
11-beta-hydroxysteroid dehydrogenase 1 5910 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
11-beta-hydroxysteroid dehydrogenase 1 1542 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 342.51 | Molecular Weight (Monoisotopic): 342.1977 | AlogP: 3.21 | #Rotatable Bonds: 1 |
| Polar Surface Area: 67.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.46 | CX LogD: 3.46 |
| Aromatic Rings: 0 | Heavy Atoms: 23 | QED Weighted: 0.79 | Np Likeness Score: 0.11 |
References
| 1. Böhme T, Engel CK, Farjot G, Güssregen S, Haack T, Tschank G, Ritter K.. (2013) 1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11ß-HSD1 inhibitors for the treatment of diabetes., 23 (16): [PMID:23845218] [10.1016/j.bmcl.2013.05.102] |
Source
Source(1):